
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
[ Tue, Mar 19th 2024 ]: WOPRAI
Joseph Pantginis Reiterated (TNYA) at Strong Buy and Held Target at $18 on, Mar 19th, 2024


🞛 This publication is a summary or evaluation of another publication
Joseph Pantginis of HC Wainwright & Co., Reiterated "Tenaya Therapeutics, Inc." (TNYA) at Strong Buy and Held Target at $18 on, Mar 19th, 2024.
Joseph has made no other calls on TNYA in the last 4 months.
There is 1 other peer that has a rating on TNYA. Out of the 1 peers that are also analyzing TNYA, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Mani Foroohar of "Leerink Partners" Initiated at Buy and Held Target at $7 on, Thursday, November 30th, 2023